U.S. Wireless Telecom Stock News

If you are wondering whether Kyivstar Group is still good value after its recent run up, or if you have already missed the boat, this breakdown will help you decide whether the current price makes sense. The stock has climbed 5.7% over the last week, 32.7% over the past month, and is now up roughly 51.0% year to date, which indicates that sentiment has shifted quickly. That momentum has come as investors refocus on Ukraine's critical digital infrastructure and the role Kyivstar plays in...

Gaming and Leisure Properties, Inc. recently appointed Michael Borofsky as a new independent director, expanding its board to eight members, seven of whom meet Nasdaq independence standards. Borofsky’s background in capital allocation, gaming investments, and complex transactions could influence how Gaming and Leisure Properties evaluates future deals, risk, and long-term capital deployment. Next, we’ll examine how adding Borofsky’s private equity and gaming experience to the board may...

AllianceBernstein Holding (AB) has been quietly grinding higher, with the stock up about 4% over the past 3 months and roughly 23% over the past year, outpacing many traditional asset managers. See our latest analysis for AllianceBernstein Holding. With the share price now around $39.85 and a 30 day share price return of 1.30 percent, the steadier 1 year total shareholder return of 22.82 percent suggests momentum is still building rather than fading. If you are weighing up where else...

In December 2025, Teva Pharmaceutical Industries obtained lender consent to extend the maturity of its senior unsecured sustainability-linked revolving credit facility from April 29, 2027, to April 29, 2028, while resetting key leverage and interest-cover covenants tied to potential Investment Grade Status. This covenant flexibility, together with recent progress in higher-margin branded and biosimilar products, gives Teva more room to align its balance sheet with its ongoing business...

Par Pacific Holdings (PARR) has been on a wild ride lately, slipping over the past week and month but still showing strong gains this year. This naturally raises questions about what is really driving the stock. See our latest analysis for Par Pacific Holdings. After such a strong run, with the share price now at $38.95 and a year to date share price return above 130 percent, the recent pullback looks more like momentum cooling than a complete change in the long term story. This is especially...

Preferred Bank (PFBC) just gave income focused investors something to consider by approving a 6.7% increase in its annual cash dividend to $3.20 per share, which signals confidence in its earnings power. See our latest analysis for Preferred Bank. The dividend bump comes after a solid run, with a year to date share price return of 16.29 percent and a five year total shareholder return of 145.36 percent, suggesting that momentum in the story is still very much alive. If this kind of steady...

MINISO Group Holding (NYSE:MNSO) is doubling down on Europe, opening Italy's first dedicated collectible toy store in Milan and its largest German location in Dusseldorf, both built around high traffic, immersive IP driven retail. See our latest analysis for MINISO Group Holding. These Milan and Dusseldorf openings arrive as the share price sits at $20.21, with the recent 90 day share price return of minus 19.26 percent contrasting a robust three year total shareholder return of 96.66...

Earlier this week, Seadrill Limited announced new contract awards for the West Neptune and Sevan Louisiana in the U.S. Gulf of Mexico, alongside a five-well option exercise in Angola that keeps the Sonangol Quenguela working into February 2027 and adds about US$48 million to its backlog. These awards not only extend rig utilization across key basins but also highlight Seadrill’s ability to secure follow-on work and deploy new well-intervention technology in the Gulf of Mexico. We’ll now look...

Wondering if Crown Holdings at around $101.53 is still a smart buy or if most of the upside has already been priced in? Here is a closer look at what the current share price really implies about its value. The stock has climbed 7.8% over the last week, 4.5% over the past month, and is up 25.0% year to date, adding to a 20.2% gain over the last year that has many investors taking a fresh look. Some of this momentum reflects renewed interest in packaging names as investors rotate toward...

Penske Automotive Group (PAG) has quietly added to recent gains, with the stock up about 6% over the past month even as its performance over the past 3 months remains slightly negative. See our latest analysis for Penske Automotive Group. Zooming out, Penske’s roughly 12% year to date share price return and strong multi year total shareholder returns suggest momentum has cooled recently, but the longer term trend still reflects solid value creation as investors reassess growth and cyclicality...

Greenbrier Companies (GBX) has quietly outperformed the broader market over the past month, even though the stock is still down sharply year to date. This invites a closer look at what investors might be missing. See our latest analysis for Greenbrier Companies. Over the past year, Greenbrier’s share price return has been weak. However, a recent 1 month share price return of 8.6 percent from around 46.6 dollars suggests momentum may be starting to rebuild as investors reassess rail related...

Intuitive Machines (LUNR) has had a choppy run lately, with the stock down over the past week but still up in the past month and past 3 months, leaving investors reassessing its risk reward profile. See our latest analysis for Intuitive Machines. The 13.1% 1 month share price return and 16.2% 3 month share price return suggest momentum is tentatively rebuilding. However, the 44.2% year to date share price decline and weaker 1 year total shareholder return show investors are still pricing in...

In the past quarter, Collegium Pharmaceutical reported a strong Q3, with revenue rising 31.4% year on year and topping analyst expectations by 10.7%, driven by its differentiated pain management medicines. The company also exceeded its full-year revenue guidance, signaling operational strength that reinforces its focus on specialty products for chronic pain. With Q3 revenue surpassing expectations by 10.7%, we’ll now examine how this performance influences Collegium’s existing investment...

If you have ever wondered whether Enterprise Products Partners is still a smart buy at today’s price, you are not alone. This breakdown is designed to give you a clear, valuation focused answer. Despite a modest pullback of around 1.7% over the last week and 1.5% over the last month, Enterprise is still up about 8.7% over the past year and 128.0% over five years. This indicates that the long term story has been much stronger than the recent noise. Recent coverage has highlighted Enterprise’s...

Corteva (CTVA) has quietly given back some gains over the past month, even as its year to date return remains solidly in positive territory, and that gap is catching investors attention. See our latest analysis for Corteva. That recent pullback sits against a backdrop of a much stronger year to date share price return of 16.2 percent and a 5 year total shareholder return of 77.5 percent, suggesting long term momentum remains intact even as near term enthusiasm cools. If Corteva has you...

If you are wondering whether Taiwan Semiconductor Manufacturing is still a smart buy after its huge run, or if you would be overpaying at today's price, you are not alone. TSM's share price has pulled back about 5.5% over the last week, but it is still up around 0.7% over 30 days and 42.3% year to date, with a 44.5% gain over 1 year and 293.5% over 3 years. That surge in returns has coincided with ongoing optimism around chip demand for AI data centers and high performance computing,...

Wondering if Exxon Mobil is still a buy after its huge run over the last few years, or if the easy money has already been made? You are not alone. Despite a 240.2% gain over 5 years and a solid 10.1% return over the last year, the stock has cooled recently, slipping 3.0% over the past week and 3.9% over the last month, while still up 6.9% year to date. Recent moves have been shaped by shifting expectations for long term oil and gas demand and renewed focus on energy security, as markets...

Wondering if Huntington Ingalls Industries is still a smart buy after its big run, or if the market has already priced in the upside? This breakdown will walk through what the current share price really implies. The stock has climbed to around $326.80, with gains of 3.8% over the last week, 4.1% over the last month, and 74.2% year to date, building on a 72.9% 1-year return and 123.6% over 5 years that has clearly shifted how investors see its prospects and risks. That re-rating has been...

Crocs (CROX) has quietly staged a comeback, with shares up roughly 25% over the past month and about 14% in the past 3 months, despite flat revenue and volatile long term returns. See our latest analysis for Crocs. Zooming out, that strong 1 month share price return contrasts with a negative year to date share price return and a weak 1 year total shareholder return, hinting that sentiment may be turning after a choppy stretch. If Crocs has you rethinking where growth might show up next in...

Occidental Petroleum (OXY) has been grinding lower, with the stock down about 9% over the past month and roughly 18% over the past 3 months, inviting a closer look at valuation and expectations. See our latest analysis for Occidental Petroleum. That slide comes after a choppy year, where the share price has delivered a weak year to date return and a negative one year total shareholder return. This suggests momentum has faded as the market reassesses energy price risks and Occidental...

Invitation Homes (INVH) just gave income focused investors something new to consider with a 3.4% increase in its quarterly dividend, along with stronger than expected revenue and higher 2025 cash flow guidance. See our latest analysis for Invitation Homes. Those stronger fundamentals have not yet translated into the share price, with a year to date share price return of negative 14.6 percent and a one year total shareholder return of negative 14.1 percent. This suggests momentum has been...

Philip Morris International (PM) has quietly turned into one of 2024’s steadier compounders, with the stock up around 30% over the past year as investors warm to its smoke free transition story. See our latest analysis for Philip Morris International. That steady grind higher has come as the market leans into Philip Morris International’s smoke free and wellness push. The latest $157.95 share price sits on the back of a roughly 30 percent year to date share price return and a 5 year total...

Cytokinetics (CYTK) just cleared two big regulatory hurdles for its heart drug MYQORZO, with full approval in China and a positive EU opinion, and that one-two punch is reshaping how investors view its pipeline. See our latest analysis for Cytokinetics. The stock has been choppy in the short term, with a 1 month share price return of minus 6.7 percent. However, a 90 day share price return above 30 percent and a 1 year total shareholder return just under 30 percent suggest momentum is still...

If you are wondering whether Centene is a beaten down bargain or a value trap at current prices, this article will walk through what the numbers are really saying about the stock. Despite being down 35.6% year to date and 32.6% over the past year, the share price has shown some recent stability, with a 2.3% gain over the last week and 7.1% over the last month. Much of the recent price action has been shaped by shifting expectations around US healthcare policy and Medicaid redeterminations,...